MELANOMAS, SARCOMAS, AND RENAL METASTASES IN THE LIVER: HOW TO TREAT?

Area of Science:

• Oncology
• Hepatology

Background:

• Liver metastases from melanoma, sarcoma, and renal tumors are infrequent.
• Treatment and prognosis are influenced by numerous factors including metastasis characteristics, patient condition, and disease stage.

Purpose of the Study:

• To review the factors influencing treatment and prognosis of liver metastases from less common primary tumors.
• To highlight recent advancements in oncological therapies for these metastases.

Main Methods:

• Review of existing literature on liver metastases from melanoma, sarcoma, and renal tumors.
• Analysis of factors affecting treatment decisions and patient outcomes.
• Examination of novel oncological and immuno-oncological treatment strategies.

Main Results:

• Prognosis is highly variable, depending on metastasis characteristics (e.g., isolated vs. multiple, size, location) and patient-specific factors (e.g., age, clinical condition).
• Extrahepatic disease presence significantly impacts prognosis.
• Recent oncological therapies, including monotherapy, combination treatments, neoadjuvants, adjuvants, and immuno-oncology, show promise.

Conclusions:

• Effective management of these rare liver metastases requires a personalized approach considering multiple clinical and pathological variables.
• Emerging oncological therapies are improving disease-free time and overall survival for patients with these challenging conditions.